Leukemia Burden Impacts the Efficacy and Toxicity of Blinatumomab in Pediatric B‐Cell Acute Lymphoblastic Leukemia

Leukemia Burden Impacts the Efficacy and Toxicity of Blinatumomab in Pediatric B‐Cell Acute Lymphoblastic Leukemia

ABSTRACT Background Blinatumomab has been approved for the treatment of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). This study aimed to investigate the association between leukemia burden and the efficacy of blinatumomab in real‐world applications. Methods A real‐world study was conducted...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiling Yan, Shaoyan Hu, Wenjin Gao, Lihua Yang, Yan Gu, Yufeng Liu, Yunyan He, Dunhua Zhou, Wenting Hu, Xue Tang, Ming Sun, Lili Song, Wenyu Yang, Yalan You, Yongmin Tang, Xiaojun Xu
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Cancer Medicine
Subjects:
acute lymphoblastic leukemia
blinatumomab
pediatric
real‐world study
Online Access:https://doi.org/10.1002/cam4.71159
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.71159

Similar Items